We are live on ! Find out more
BMRA icon

Biomerica

35 hedge funds and large institutions have $3.43M invested in Biomerica in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% less ownership

Funds ownership: 3.28%2.97% (-0.31%)

3% less funds holding

Funds holding: 3635 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

43% less capital invested

Capital invested by funds: $6M → $3.43M (-$2.57M)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BMRA Hedge Fund Activity: Q3 2023 in Review

35 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q3 2023, worth a combined $3.43M — down 43% from $6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BMRA and 3 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 5 added.

The largest buyer was Granahan Investment Management, adding an estimated $22.3K. The largest seller was Potomac Capital Management, cutting an estimated $287K.

  • 35 institutional investors held Biomerica (BMRA) as of Q3 2023, down from 36 in Q2 2023.
  • Funds reported $3.43M of Biomerica stock for Q3 2023, down 43% quarter-over-quarter.
  • 3 funds opened new Biomerica positions in Q3 2023 and 4 closed out, a net change of -1 holder.
  • The largest Biomerica buyer in Q3 2023 was Granahan Investment Management, an estimated $22.3K added.
  • The largest Biomerica seller in Q3 2023 was Potomac Capital Management, an estimated $287K sold.

Based on aggregated 13F filings for Q3 2023.